CA 125 and the detection of recurrent ovarian cancer
A reasonably accurate biomarker for a difficult disease |
| Robert C. Bast Jr, MD |
| Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas |
| Abstract |
| Rising cancer antigen 125 (CA125) levels have been used to detect recurrence of ovarian cancer. A recent study questions the value of this practice, but the clinical trial has significant limitations and discounts the value of early detection to permit treatment of recurrence with novel and conventional agents. |
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.